Impact of Amrubicin Monotherapy as Second-Line Chemotherapy on Outcomes in Elderly Patients with Relapsed Extensive-Disease Small-Cell Lung Cancer

Impact of Amrubicin Monotherapy as Second-Line Chemotherapy on Outcomes in Elderly Patients with Relapsed Extensive-Disease Small-Cell Lung Cancer

Satoshi Igawa,1 Taihei Ono,1 Masashi Kasajima,1 Hideaki Manabe,1 Tomoya Fukui,1 Hisashi Mitsufuji,2 Masanori Yokoba,3 Masaru Kubota,3 Masato Katagiri,3 Jiichiro Sasaki,4 Katsuhiko Naoki1 1Department of Respiratory Medicine, Kitasato University School of Medicine, Sagamihara-City, Kanagawa 252-0374,...

Full description

Bibliographic Details
Main Authors: Igawa S, Ono T, Kasajima M, Manabe H, Fukui T, Mitsufuji H, Yokoba M, Kubota M, Katagiri M, Sasaki J, Naoki K
Format: Article
Language:English
Published: Dove Medical Press 2020-06-01
Series:Cancer Management and Research
Subjects:
small cell lung cancer
amrubicin
elderly
second-line chemotherapy
modified glasgow prognostic score
Online Access:https://www.dovepress.com/impact-of-amrubicin-monotherapy-as-second-line-chemotherapy-on-outcome-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/impact-of-amrubicin-monotherapy-as-second-line-chemotherapy-on-outcome-peer-reviewed-article-CMAR

Similar Items